25-Hydroxyvitamin D Levels and Survival in Advanced Pancreatic Cancer: Findings From CALGB 80303 (Alliance)

Racial Disparities in Gastrointestinal Cancers-Related Mortality in the US Population

(2012) Raxitkumar Jinjuvadia et al.   DIGESTIVE DISEASES AND SCIENCES

A Genome-Wide Association Study of Overall Survival in Pancreatic Cancer Patients Treated with Gemcitabine in CALGB 80303

(2011) F. Innocenti et al.   CLINICAL CANCER RESEARCH

Vitamin D Status in Patients With Stage IV Colorectal Cancer: Findings From Intergroup Trial N9741

(2011) Kimmie Ng et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic Role of Vitamin D Status and Efficacy of Vitamin D Supplementation in Cancer Patients: A Systematic Review

(2011) C. Buttigliero et al.   ONCOLOGIST

Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)

(2010) Hedy Lee Kindler et al.   JOURNAL OF CLINICAL ONCOLOGY

Vitamin D: newly discovered actions require reconsideration of physiologic requirements

(2010) Daniel D. Bikle   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Demographic Differences and Trends of Vitamin D Insufficiency in the US Population, 1988-2004

(2009) Adit A. Ginde et al.   ARCHIVES OF INTERNAL MEDICINE

An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D

(2009) Dennis Wagner et al.   CLINICAL BIOCHEMISTRY

High Prevalence of Vitamin D Deficiency Despite Supplementation in Premenopausal Women With Breast Cancer Undergoing Adjuvant Chemotherapy

(2009) Katherine D. Crew et al.   JOURNAL OF CLINICAL ONCOLOGY

Vitamin D Status: Measurement, Interpretation, and Clinical Application

(2008) Michael F. Holick   ANNALS OF EPIDEMIOLOGY